Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia (BPH)

Asian Journal of Urology, 2015, 2 (2): 102-106 doi:

Review

Current Issue | Archive | Adv Search

Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia (BPH)

Bilal Chughtai, Leanna Laor, Claire Dunphy, Alexis Te

Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA

Abstract
Related Citation (13)

Download:

HTML

PDF (322KB)
Export: BibTeX | EndNote (RIS)

Abstract Benign prostatic hyperplasia (BPH) is a condition that occurs increasingly with age. The established gold standard treatment for BPH has been the electrocautery-based transurethral resection of the prostate (TURP). TURP, however, is associated with several complications and side effects. Therefore, there is an increasing interest in a number of emerging minimally invasive therapies as alterative treatment options. Laser therapy using the Greenlight laser is a promising alternative to the traditional TURP. Selective absorption by hemoglobin allows rapid, hemostatic vaporization of prostate tissue. Additional advantages include avoidance or minimization of complications such as intraoperative fluid absorption, bleeding, retrograde ejaculation, impotence, and incontinence, as well as its use in treating high volume BPH.We review the use of the Greenlight laser in the treatment of BPH, when comparing complications and advantages in relation to TURP.

Key words： Benign prostatic hyperplasia Laser prostatectomy 532 nm prostatectomy

Published: 30 April 2015

Corresponding Authors: Bilal Chughtai E-mail: bic9008@med.cornell.edu

	Service
	E-mail this article
	Add to citation manager
	E-mail Alert
	Articles by authors
	Bilal Chughtai
	Leanna Laor
	Claire Dunphy
	Alexis Te

TRENDMD:

Cite this article:

Bilal Chughtai,Leanna Laor,Claire Dunphy, et al. Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia (BPH)[J]. Asian Journal of Urology, 2015, 2(2): 102-106.

URL:

http://www.ajurology.com/EN/ OR http://www.ajurology.com/EN/Y2015/V2/I2/102

[1]	Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004;171(6 Pt 1):2502-4.
[2]	Lee R, Saini R, Zoltan E, Te AE. Photoselective vaporization of the prostate using a laser high performance system in the canine model. J Urol 2008;180:1551-3.
[3]	Kang HW, Jebens D, Malek RS, Mitchell G, Koullick E. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol 2008;180:2675-80.
[4]	Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005;173:158-60.
[5]	Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-8.
[6]	Woo H, Reich O, Bachmann A, Choi B, Collins E. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (I 80 ml). Eur Urol Suppl 2008;7:378-83.
[7]	Sandhu JS, Ng CK, VanderBrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-9.
[8]	Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, et al. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int 2008;102:322-7.
[9]	De Nunzio C, Miano R, Trucchi A, Miano L, Franco G, Squillacciotti S, et al. Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms. J Urol 2010;183:1098-103.
[10]	Batura D, Sahibzada I, Elkabir J, Feyisetan O, Izegbu V, Hellawell G, et al. Durability and complications of photoselective vaporisation of the prostate with the 120 W high performance system greenlight lithium triborate laser. Ann R Coll Surg Engl 2014;96:359-63.
[11]	Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol 2009;23:495-502.
[12]	Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol 2014;65:931-42.
[13]	Malek RS, Barrett DM, Kuntzman RS. High-power potassiumtitanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998;51:254-6.
[14]	Malek RS, Kuntzman RS, Barrett DM. High power potassiumtitanyl-phosphate laser vaporization prostatectomy. J Urol 2000;163:1730-3.
[15]	Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17:93-6.
[16]	Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172(4 Pt 1):1404-8.
[17]	Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20:580-5.
[18]	Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology 2008;71:247-51.
[19]	Ouyang Y, Liu C, Guan W, Zhao Y, Xu Y, Wu Y.Impact of 160 W Greenlight laser vaporization of the prostate on erectile function: a prospective randomized controlled trial with 1-year follow-up. Photomed Laser Surg 2014;32:463-7.
[20]	Altay B, Erkurt B, Kiremit MC, Guzelburc V, Boz MY, Albayrak S. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci 2015;30:317-23.
[21]	Emara A, Barber N. The continuous evolution of the Greenlight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol 2014;28:73-8.
[22]	Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008;54:893-901.